Page last updated: 2024-09-03

rwj 26629 and rubidium

rwj 26629 has been researched along with rubidium in 1 studies

Compound Research Comparison

Studies
(rwj 26629)
Trials
(rwj 26629)
Recent Studies (post-2010)
(rwj 26629)
Studies
(rubidium)
Trials
(rubidium)
Recent Studies (post-2010) (rubidium)
5005,16318269

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Falotico, R; Giardino, EC; Katz, LB; Moore, JB; Salata, JJ1

Other Studies

1 other study(ies) available for rwj 26629 and rubidium

ArticleYear
RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:2

    Topics: Angina Pectoris; Animals; Antihypertensive Agents; Benzopyrans; Bronchoconstriction; Calcium Channel Blockers; Cromakalim; Dogs; Dose-Response Relationship, Drug; Female; Ferrets; Gastrointestinal Motility; Guinea Pigs; Heart Atria; Macaca mulatta; Male; Mice; Mice, Inbred Strains; Muscle Relaxation; Muscle, Smooth, Vascular; Nitrendipine; Papillary Muscles; Pilocarpine; Potassium Channels; Pyrans; Pyrroles; Rabbits; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rubidium; Rubidium Radioisotopes; Thiophenes; Vasodilator Agents

1993
chemdatabank.com